Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Antoine Lacassagne
About this trial
Research into biomarkers predictive of survival and response to cancer treatment
Eligibility criteria
Qualifiers
Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
Patient who has read the information note and stated that he/she has no objections
Patient who has not objected to the use of this data for medical research purposes
Patient with social security cover.
Disqualifiers
Patient already included in the study
Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8
Trial design
Treatments tested in this trial
- blood sampling
Treatment groups
40,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov